World Journal of Gastroenterology · 2005 · 102 citations · 23 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyHepatic PharmacotherapyHepatologyHepatic EncephalopathyHepatic Encephalopathy TreatmentHepatic ImpairmentHepatic PathophysiologyLiver DiseaseViral HepatitisAmmonia-lowering TreatmentBlock Design TestHepatic Encephalopathy ManagementMetabolic EncephalopathySymbol Digit Modalities Test
AIM: To evaluate the influence of L-carnitine on mental conditions and ammonia effects on patients with hepatic encephalopathy (HE). METHODS: One hundred and fifty patients (10 patients with alcoholism, 41 patients with hepatitis virus B infection, 78 patients with hepatitis C virus infection, 21 patients with cryptogenetic cirrhosis) meeting the inclusion criteria were randomized into group A receiving a 90-d treatment with L-carnitine (2 g twice a day) or into group B receiving placebo in double blind. RESULTS: At the end of the study period, a significant decrease in NH4 fasting serum levels was found in patients with hepatic encephalopathy (P<0.05) after the treatment with levocarnitine (LC). Significant differences were also found between symbol digit modalities test and block design in patients with hepatic encephalopathy (P<0.05). CONCLUSION: Results of our study suggest an important protective effect of L-carnitine against ammonia-precipitated encephalopathy in cirrhotic patients.
23
Transection of the oesophagus for bleeding oesophageal varices
R. N. H. Pugh, I M Murray-Lyon, J L Dawson et al. · British journal of surgery · 1973 · 8K citations